Create an Account

Women's Health 2022: Beyond the Annual Visit - West - December 9, 2022

During any visit, we must use a far broader lens on issues facing the female patient. That’s why there’s Women’s Health 2022: Beyond the Annual Visit.

Live Broadcast
6.75 available credits
Information
December 09, 2022
08:00 AM - 04:00 PM PST
Virtual
ReachMD Healthcare Image
Details
Presenters
Related
Comments

  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2022: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts discussing the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson and Ms. Barbara Dehn as this year's Co-Program Chairs and Moderators!

    Join the conversation #WH22

    Please see below for when the Live Broadcast will begin in your time zone:

    • 10 AM CT
    • 11 AM ET
    • 9 AM MT
    • 8 AM PT

     

    Please email info@omniaeducation.com if you have any questions.

  • Program Schedule*

     

     

    8:00 am–8:05 am

    Welcome, Introductions, Program Announcements

     

     


    Session 1

     

     

     

    8:05 am–8:50 am

    Uterine Fibroids: Patient-Centered Care for Timely Diagnosis and Shared Treatment Decisions

     

     

    8:50 am–9:35 am

    EndoShare 2022: A Patient-Centered, Evidence-Based Approach to Managing Endometriosis Pain

     

     

    9:35 am–10:05 am

    Question & Answer Session

     

     

    10:05 am–10:15 am

    Break

     

     


    Session 2

     

    10:15 am–10:55 am

    Spanning the Spectrum of VVC: Diagnosing and Managing Acute and Recurrent Disease

     

     

    10:55 am–11:30 am

    Mental Health and Menopause: Patient-Centric Approaches

     

     

    11:30 am–12:10 pm

    Let’s Discuss Postpartum Depression: Screening, Diagnosis, and Management

     

     

    12:10 pm–12:40 pm

    Question & Answer Session

     

     

    12:40 pm–1:10 pm

    Break

     

     


    Session 3

     

    1:10 pm–1:45 pm

    Long-Acting Reversible Contraceptives: Their Critical Role in Addressing Today’s Reproductive Health Landscape

     

     

    1:45 pm–2:15 pm

    Office Diagnosis and Management of Urinary Incontinence in Women

     

     

    2:15 pm–2:45 pm

    Office Diagnosis and Treatment for Pelvic Relaxation

     

     

    2:45 pm–3:20 pm

    Adolescent Sexuality in the Age of Social Media

     

     

    3:20 pm–3:50 pm

    Question & Answer Session

     

     

    3:50 pm–4:00 pm

    Closing Remarks

     

     

    *Subject to change

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Hosts:
    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology
    David Geffen School of Medicine at UCLA
    Clinical Professor Obstetrics & Gynecology
    University Southern California, Los Angeles, CA

    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research:  Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Barbara Dehn, RN, MS, NP, FAANP, NCMP
    Nurse Practitioner
    El Camino Women's Medical Group
    Mountain View, CA

    No relevant relationship reported

    Faculty:
    Anita H. Clayton, MD
    Professor & Chair
    Department of Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA

    Contracted Research: Daré Bioscience, Janssen, Otsuka, Praxis Precision Medicines, Relmada Therapeutics, Inc., Sage Therapeutics, Takeda
    Consulting Fees: Fabre-Kramer, Janssen Research & Development, LLC., Mind Cure Health, Ovoca Bio PLD, PureTech Health, Reunion Neuroscience (formerly Field Trip Health), S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck; Vella Bioscience, Inc, WCG MedAvante-ProPhase
    Ownership Interest: Euthymics, Mediflix LLC, S1 Biopharma
    Royalty: Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; Guilford Publications

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University in St. Louis School of Medicine
    St. Louis, MO

    Research: Evofem Biosciences, Medicines 360, Merck
    Ownership Interest: Femasys Inc.
    Consulting Fees: Evofem Biosciences, Femasys Inc., Medicines360, ACI Clinical/Sebela Pharmaceuticals

    Andrew M. Kaunitz, MD, FACOG, NCMP
    Tenured Professor & Associate Chair
    Obstetrics & Gynecology
    University of Florida College of Medicine-Jacksonville
    Jacksonville, FL

    Research: Bayer
    Consulting Fees: Myovant Sciences

    Michael L. Krychman, MD
    Clinical Health Professor OB/GYN
    Obstetrics and Gynecology
    Department of OB/Gyn
    Division of Gynecologic Oncology
    Anne’s Clinic
    University of California, Irvine
    Orange, CA

    Consulting Fees: SCYNEXIS

    Jennifer L. Payne, MD
    Professor and Vice Chair of Research
    Department of Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA

    Consulting Fees: Brii Bio CNS, Karuna, Pure Tech, SAGE Therapeutics

    Hugh S. Taylor, MD
    Anita O’Keeffe Young Professor and Chair
    Department of Obstetrics, Gynecology and Reproductive Sciences
    Yale School of Medicine
    New Haven, CT

    No relevant relationship reported

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Nick Lombardi has no relevant relationships to report.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family practice, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.75 Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by independent educational grants from AbbVie, Astellas, Biogen, Inc., Organon LLC, Sage Therapeutics, Inc., and SCYNEXIS.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Presenters

Related

Facebook Comments

Details
Presenters
Related
Comments

  • Overview

    Designed for women's health and primary care specialties, Women’s Health 2022: Beyond the Annual Visit is a complimentary, full-day CME live broadcast featuring experts discussing the latest screening, diagnostic, and treatment guidelines to help healthcare professionals provide the best possible care for the whole female patient.

    We're excited to announce Dr. Anita Nelson and Ms. Barbara Dehn as this year's Co-Program Chairs and Moderators!

    Join the conversation #WH22

    Please see below for when the Live Broadcast will begin in your time zone:

    • 10 AM CT
    • 11 AM ET
    • 9 AM MT
    • 8 AM PT

     

    Please email info@omniaeducation.com if you have any questions.

  • Program Schedule*

     

     

    8:00 am–8:05 am

    Welcome, Introductions, Program Announcements

     

     


    Session 1

     

     

     

    8:05 am–8:50 am

    Uterine Fibroids: Patient-Centered Care for Timely Diagnosis and Shared Treatment Decisions

     

     

    8:50 am–9:35 am

    EndoShare 2022: A Patient-Centered, Evidence-Based Approach to Managing Endometriosis Pain

     

     

    9:35 am–10:05 am

    Question & Answer Session

     

     

    10:05 am–10:15 am

    Break

     

     


    Session 2

     

    10:15 am–10:55 am

    Spanning the Spectrum of VVC: Diagnosing and Managing Acute and Recurrent Disease

     

     

    10:55 am–11:30 am

    Mental Health and Menopause: Patient-Centric Approaches

     

     

    11:30 am–12:10 pm

    Let’s Discuss Postpartum Depression: Screening, Diagnosis, and Management

     

     

    12:10 pm–12:40 pm

    Question & Answer Session

     

     

    12:40 pm–1:10 pm

    Break

     

     


    Session 3

     

    1:10 pm–1:45 pm

    Long-Acting Reversible Contraceptives: Their Critical Role in Addressing Today’s Reproductive Health Landscape

     

     

    1:45 pm–2:15 pm

    Office Diagnosis and Management of Urinary Incontinence in Women

     

     

    2:15 pm–2:45 pm

    Office Diagnosis and Treatment for Pelvic Relaxation

     

     

    2:45 pm–3:20 pm

    Adolescent Sexuality in the Age of Social Media

     

     

    3:20 pm–3:50 pm

    Question & Answer Session

     

     

    3:50 pm–4:00 pm

    Closing Remarks

     

     

    *Subject to change

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Hosts:
    Anita L. Nelson, MD
    Professor and Chair of Obstetrics & Gynecology
    Western University of Health Sciences, Pomona, CA
    Professor Emeritus, Obstetrics & Gynecology
    David Geffen School of Medicine at UCLA
    Clinical Professor Obstetrics & Gynecology
    University Southern California, Los Angeles, CA

    Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD
    Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
    Contracted Research:  Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals

    Barbara Dehn, RN, MS, NP, FAANP, NCMP
    Nurse Practitioner
    El Camino Women's Medical Group
    Mountain View, CA

    No relevant relationship reported

    Faculty:
    Anita H. Clayton, MD
    Professor & Chair
    Department of Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA

    Contracted Research: Daré Bioscience, Janssen, Otsuka, Praxis Precision Medicines, Relmada Therapeutics, Inc., Sage Therapeutics, Takeda
    Consulting Fees: Fabre-Kramer, Janssen Research & Development, LLC., Mind Cure Health, Ovoca Bio PLD, PureTech Health, Reunion Neuroscience (formerly Field Trip Health), S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck; Vella Bioscience, Inc, WCG MedAvante-ProPhase
    Ownership Interest: Euthymics, Mediflix LLC, S1 Biopharma
    Royalty: Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; Guilford Publications

    David L. Eisenberg, MD, MPH, FACOG
    Associate Professor
    Department of Obstetrics & Gynecology
    Washington University in St. Louis School of Medicine
    St. Louis, MO

    Research: Evofem Biosciences, Medicines 360, Merck
    Ownership Interest: Femasys Inc.
    Consulting Fees: Evofem Biosciences, Femasys Inc., Medicines360, ACI Clinical/Sebela Pharmaceuticals

    Andrew M. Kaunitz, MD, FACOG, NCMP
    Tenured Professor & Associate Chair
    Obstetrics & Gynecology
    University of Florida College of Medicine-Jacksonville
    Jacksonville, FL

    Research: Bayer
    Consulting Fees: Myovant Sciences

    Michael L. Krychman, MD
    Clinical Health Professor OB/GYN
    Obstetrics and Gynecology
    Department of OB/Gyn
    Division of Gynecologic Oncology
    Anne’s Clinic
    University of California, Irvine
    Orange, CA

    Consulting Fees: SCYNEXIS

    Jennifer L. Payne, MD
    Professor and Vice Chair of Research
    Department of Psychiatry and Neurobehavioral Sciences
    University of Virginia
    Charlottesville, VA

    Consulting Fees: Brii Bio CNS, Karuna, Pure Tech, SAGE Therapeutics

    Hugh S. Taylor, MD
    Anita O’Keeffe Young Professor and Chair
    Department of Obstetrics, Gynecology and Reproductive Sciences
    Yale School of Medicine
    New Haven, CT

    No relevant relationship reported

    Reviewers/Content Planners/Authors:

    • Sean T. Barrett has nothing to disclose.
    • Stephen Chavez has nothing to disclose.
    • Cindy Davidson has nothing to disclose.
    • Barry A. Fiedel, PhD, has nothing to disclose.
    • Nick Lombardi has no relevant relationships to report.
    • Brian P. McDonough, MD, FAAFP, has nothing to disclose.
    • Kate Nagele has nothing to disclose.
    • Estelle Perera has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
    • Robert Schneider, MSW, has nothing to disclose.

  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, primary care, family practice, and internal medicine.

  • Accreditation and Credit Designation Statements

    In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    Global Learning Collaborative (GLC) designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Global Learning Collaborative (GLC) designates this activity for 6.75 Nursing contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.

  • Commercial Support

    This activity is supported by independent educational grants from AbbVie, Astellas, Biogen, Inc., Organon LLC, Sage Therapeutics, Inc., and SCYNEXIS.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Presenters

Related

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00
    Register

    We’re glad to see you’re enjoying Omnia Education…
    but how about a more personalized experience?

    Register for free
    You are now leaving Omnia Education and going to a site run by another organization.

    Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.